1. Home
  2. BZUN vs KZIA Comparison

BZUN vs KZIA Comparison

Compare BZUN & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$3.60

Market Cap

164.5M

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

BUY

Current Price

$7.85

Market Cap

186.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BZUN
KZIA
Founded
2007
1994
Country
China
Australia
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
186.7M
IPO Year
2014
2002

Fundamental Metrics

Financial Performance
Metric
BZUN
KZIA
Price
$3.60
$7.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$4.58
★ $28.33
AVG Volume (30 Days)
★ 369.5K
229.9K
Earning Date
11-24-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.08
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$4.86
52 Week High
$3.92
$17.40

Technical Indicators

Market Signals
Indicator
BZUN
KZIA
Relative Strength Index (RSI) 59.76 37.13
Support Level $2.57 $6.72
Resistance Level N/A $8.18
Average True Range (ATR) 0.22 0.68
MACD 0.00 0.09
Stochastic Oscillator 56.08 40.26

Price Performance

Historical Comparison
BZUN
KZIA

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: